Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Conroy, K. Pyörälä, A. Fitzgerald, S. Sans, A. Menotti, G. Backer, D. Bacquer, P. Ducimetière, P. Jousilahti, U. Keil, I. Njølstad, R. Oganov, T. Thomsen, H. Tunstall-Pedoe, A. Tverdal, H. Wedel, P. Whincup, L. Wilhelmsen, I. Graham, I. Graham (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.European heart journal, 24 11
(2006)
Studiul SEPHAR-Studiu de prevalență a hipertensiunii arteriale și evaluare a riscului cardiovascular în România
S. Wållberg-Jonsson, H. Johansson, Marie-Louise Öhman, S. Rantapää-Dahlqvist (1999)
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.The Journal of rheumatology, 26 12
M. Dorobanțu, E. Bădilă, S. Ghiorghe, R. Darabont, M. Olteanu, P. Flondor (2008)
Total cardiovascular risk estimation in Romania. Data from the SEPHAR study.Romanian journal of internal medicine = Revue roumaine de medecine interne, 46 1
Marjolein Peters, D. Symmons, D. Mccarey, B. Dijkmans, P. Nicola, T. Kvien, I. McInnes, H. Haentzschel, M. González-Gay, S. Provan, A. Semb, P. Sidiropoulos, G. Kitas, Y. Smulders, M. Soubrier, Z. Szekanecz, N. Sattar, M. Nurmohamed (2009)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisAnnals of the Rheumatic Diseases, 69
K. Kotseva, D. Wood, G. Backer, D. Bacquer, K. Pyörälä, Ž. Reiner, U. Keil (2010)
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countriesEuropean Journal of Preventive Cardiology, 17
G. Mancia, S. Laurent, E. Agabiti-Rosei, E. Ambrosioni, M. Burnier, M. Caulfield, R. Cífková, D. Clement, A. Coca, A. Dominiczak, S. Erdine, R. Fagard, C. Farsang, G. Grassi, H. Haller, A. Heagerty, S. Kjeldsen, W. Kiowski, J. Mallion, A. Manolis, K. Narkiewicz, P. Nilsson, M. Olsen, K. Rahn, J. Redón, J. Rodicio, L. Ruilope, R. Schmieder, H. Struijker-Boudier, P. Zwieten, M. Viigimaa, A. Zanchetti (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documentJournal of Hypertension, 27
F. Arnett, S. Edworthy, D. Bloch, D. McShane, J. Fries, N. Cooper, L. Healey, S. Kaplan, M. Liang, H. Luthra, T. Medsger, D. Mitchell, D. Neustadt, R. Pinals, J. Schaller, J. Sharp, R. Wilder, G. Hunder (1988)
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis and rheumatism, 31 3
I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cífková, J. Dallongeville, G. Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, Stephen Humphries, M. Knapton, J. Perk, S. Priori, K. Pyôrâlà, Ž. Reiner, L. Ruilope, Susana Sans-Menendez, W. Reimer, P. Weissberg, D. Wood, J. Yarnell, J. Zamorano, E. Walma, T. Fitzgerald, M. Cooney, A. Dudina, A. Vahanian, John Camm, R. Caterina, V. Dean, Kenneth Dickstein, C. Funck-Brentano, G. Filippatos, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, Petr Widimsky, J. Zamorano, Attila Altiner, E. Bonora, P. Durrington, R. Fagard, Simona Giampaoli, H. Hemingway, Jan Hakansson, S. Kjeldsen, Mogens Larsen, G. Mancia, A. Manolis, K. Orth-Gomér, Terje Pedersen, Mike Rayner, Lars Rydén, Mario Sammut, N. Schneiderman, Anton Stalenhoef, L. Tokgözoğlu, Olov Wiklund, A. Zampelas (2007)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invitEuropean journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 14 Suppl 2
S. Gabriel (2008)
Why do people with rheumatoid arthritis still die prematurely?Annals of the Rheumatic Diseases, 67
J. Banegas, E. López-García, J. Dallongeville, E. Guallar, J. Halcox, C. Borghi, E. Massó-González, F. Jiménez, J. Perk, P. Steg, G. Backer, F. Rodríguez‐Artalejo (2011)
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyEuropean Heart Journal, 32
(2008)
Why do persons with rheumatoid arthritis still die prematurely
H. Kremers, M. Bidaut‐Russell, C. Scott, M. Reinalda, A. Zinsmeister, S. Gabriel (2003)
Preventive medical services among patients with rheumatoid arthritis.The Journal of rheumatology, 30 9
Doina Bunescu, H. Stoffers, M. Akker, Geert Dinant (2008)
Coronary heart disease and cardiovascular risk factors among people aged 25–65 years, as seen in Romanian primary healthcareThe European Journal of General Practice, 14
A. Semb, T. Kvien, D. Demicco, R. Fayyad, C. Wun, J. Larosa, J. Betteridge, T. Pedersen, I. Holme (2012)
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.Arthritis and rheumatism, 64 9
T. Toms, V. Panoulas, K. Douglas, H. Griffiths, N. Sattar, Jaqueline Smith, D. Symmons, P. Nightingale, G. Metsios, G. Kitas (2009)
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?Annals of the Rheumatic Diseases, 69
J. Lindhardsen, Ole Ahlehoff, G. Gislason, O. Madsen, J. Olesen, C. Torp-Pedersen, P. Hansen (2012)
Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort studyAnnals of the Rheumatic Diseases, 71
J. Perk, G. Backer, H. Gohlke, I. Graham, Željko Reiner, W. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cífková, C. Deaton, S. Ebrahim, Miles Fisher, G. Germano, R. Hobbs, A. Hoes, Ş. Karadeniz, A. Mezzani, E. Prescott, L. Rydén, M. Scherer, M. Syvänne, W. Reimer, C. Vrints, D. Wood, J. Zamorano, F. Zannad, Developed Rehabilitation (2012)
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)International Journal of Behavioral Medicine, 19
M. Vera, Hyon Choi, M. Abrahamowicz, J. Kopec, M. Goycochea-Robles, D. Lacaille (2011)
Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort studyAnnals of the Rheumatic Diseases, 70
T. Toms, Jacqueline Smith, V. Panoulas, K. Douglas, A. Saratzis, G. Kitas (2010)
Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients.Musculoskeletal care, 8 1
Abstract Introduction: Rheumatoid arthritis patients have an increased risk of cardiovascular morbidity and mortality. Consecrated cardiovascular risk management strategies are underused in this patients. The purpose of this paper is to evaluate, in rheumatoid arthritis hospitalized patients, the level of cardiovascular risk and the degree of implementation of currently recommended cardiovascular risk reduction treatments. Materials and methods : 130 active rheumatoid arthritis patients, consecutively admitted in the Rheumatology Clinic of our hospital, were evaluated based on clinical exam, routine biochemistry, X-ray, electrocardiogram and cardiac ultrasound. We noted the characteristics of the rheumatic disease, the cardiovascular risk factors and organic heart disease. The risk for cardiac death at 10 years was estimated using the SCORE table; and adequate use of cardiovascular risk reduction therapies (antiaggregants, statin, antihypertensive medication) was checked. Results : Organic heart disease was identified in 28.4% of the patients. The most frequent encountered risk factors were dyslipidemia (62.3%), hypertension (54.6%) and abdominal obesity (53%). Globally, 66,1% of the patients were classified as having high cardiovascular risk. Hypertension and dyslipidemia were treated in 81.6%, respective 40.7% of the cases and controlled to recommended therapeutic goals in 70.4%, respective 22.2%. Among the patients with a symptomatic atherosclerotic disease, less than one half (48.6%) were treated with antiaggregants. Conclusion: Organic heart disease was frequent among rheumatoid arthritis patients; the most prevalent cardiovascular risk factors were hypertension, dyslipidemia and abdominal obesity. The treatment and control rates for hypertension were acceptable, but statins and antiaggregants were grossly underused.
ARS Medica Tomitana – de Gruyter
Published: Aug 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.